NATIONAL MEDICAL SERVICES:1106803 [19-000891]

美国国立卫生研究院（NIH）神经生物库由国家精神卫生研究所（NIMH）、尤尼斯·肯尼迪·施莱弗国家儿童健康与人类发展研究所（NICHD）和国家神经疾病与中风研究所（NINDS）组成，为神经、精神和神经发育障碍的研究提供死后人类脑组织。由6个大脑和组织库组成的联盟组成了NIH神经生物库，并提供了一种通过更大的标准化和成本节约来协调这一重要研究资源的方法。作为美国国立卫生研究院神经生物银行工作的一部分，一个实验室正在寻求为捐赠者的血液、大脑、尿液和头发样本中的滥用、非法和治疗药物提供测试。自授予之日起，履行期限为五年。这些检测将包括筛选多种药物类别/类型。在这个项目下测试的大多数药物将是滥用药物或精神药物。承包商可能被要求对给定组织进行联合检测，或根据要求服务的调查人员的需要和NIH NeuroBioBank项目优先级评估几种组织类型（如血液、大脑、尿液和头发）中的特定药物。

The National Institutes of Health (NIH) NeuroBioBank, comprised of the National Institute of Mental Health (NIMH), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Neurological Disorders and Stroke (NINDS), provides post-mortem human brain tissue for research on neurological, psychiatric and neurodevelopmental disorders. A federation of six brain and tissue repositories comprise the NIH NeuroBioBank and offers a means to coordinate this important research resource through greater standardization and cost savings. As part of the NIH NeuroBioBank effort a laboratory is sought to provide testing for abused, illicit and therapeutic drugs in blood, brain, urine and hair samples from donors. The period of performance is five years from the date of award. These assays will include screens for multiple drug classes/types. The majority of agents to be tested under this program will be drugs of abuse or psychotropic drugs. The Contractor may be required to do a comiantion of assays on a given tissue, or assess a particular drug in several tissue types (e.g. blood, brain, urine and hair) according to the needs of investigators requesting services and NIH NeuroBioBank programmatic priorities.